Although there is some evidence for the predictive significance of particular biomarkers regarding responses to the treatment of TRD (e.g., IL-6, CRP, BDNF), the majority of the results are either single-study reports or studies with conflicting results. The gene discussed is BDNF; the disease is treatment resistant depression.